Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 28 09 2023
accepted: 24 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

To analyse how the key components at the time of diagnosis of the Sjögren's phenotype (epidemiological profile, sicca symptoms, and systemic disease) can be influenced by the potential exposure to climate-related natural hazards. For the present study, the following variables were selected for harmonisation and refinement: age, sex, country, fulfilment of 2002/2016 criteria items, dry eyes, dry mouth, and overall ESSDAI score. Climate-related hazards per country were defined according to the OECD and included seven climate-related hazard types: extreme temperature, extreme precipitation, drought, wildfire, wind threats, river flooding, and coastal flooding. Climatic variables were defined as dichotomous variables according to whether each country is ranked among the ten countries with the most significant exposure. After applying data-cleaning techniques and excluding people from countries not included in the OECD climate rankings, the database study analysed 16,042 patients from 23 countries. The disease was diagnosed between 1 and 3 years earlier in people living in countries included among the top 10 worst exposed to extreme precipitation, wildfire, wind threats, river flooding, and coastal flooding. A lower frequency of dry eyes was observed in people living in countries exposed to wind threats, river flooding, and coastal flooding, with a level of statistical association being classified as strong (p<0.0001 for the three variables). The frequency of dry mouth was significantly lower in people living in countries exposed to river flooding (p<0.0001) and coastal flooding (p<0.0001). People living in countries included in the worse climate scenarios for extreme temperature (p<0.0001) and river flooding (p<0.0001) showed a higher mean ESSDAI score in comparison with people living in no-risk countries. In contrast, those living in countries exposed to worse climate scenarios for wind threats (p<0.0001) and coastal flooding (p<0.0001) showed a lower mean ESSDAI score in comparison with people living in no-risk countries. Local exposure to extreme climate-related hazards plays a role in modulating the presentation of Sjögren across countries concerning the age at which the disease is diagnosed, the frequency of dryness, and the degree of systemic activity.

Identifiants

pubmed: 38019164
pii: 20405
doi: 10.55563/clinexprheumatol/pmbay6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Xu Dong (X)
Zhao Yan (Z)
Xiaomei Li (X)
Li Wang (L)
Peter Olsson (P)
Thomas Mandl (T)
Raphaèle Seror (R)
Xavier Mariette (X)
Arjan Vissink (A)
Hendrika Bootsma (H)
Debashish Danda (D)
Vasco C Romão (VC)
Matilde Bandeira (M)
Manuel Silvério-António (M)
Roser Solans (R)
Carlos Galisteo (C)
Demian Sene (D)
David Isenberg (D)
Paola Cipriani (P)
Valerie Devauchelle (V)
Tamer Gheita (T)
Marcos Vázquez (M)
Jacques Morel (J)
Sandra Consani (S)
S-K Kwok (SK)
S-H Park (SH)
Marika Kvarnstrom (M)
Marie Wahren-Herlenius (M)
P Ericka Diaz (PE)
B E Herrera (BE)
Toshimasa Shimizu (T)
Andres González García (A)
Sheila Melchor-Díaz (S)
Michele Bombardieri (M)
Adrian Lees (A)
Suzanne Arends (S)
Elena Treppo (E)
Simone Longhino (S)
Valeria Manfrè (V)
Maria Teresa Rizzo (MT)
B Fazzi (B)
Agata Sebastian (A)
Piotr Wiland (P)
Roberto Gerli (R)
Sarah Downie-Doyle (S)
Alain Saraux (A)
César Morcillo (C)
Lluis González-de-Paz (L)
Antonio Sisó-Almirall (A)
Cecilia Fugmann (C)

Auteurs

Alejandra Flores-Chávez (A)

Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

Pilar Brito-Zerón (P)

Autoimmune Diseases Unit, Research and Innovation Group in Autoimmune Diseases, Sanitas Digital Hospital, Hospital-CIMA-Centre Mèdic Milenium Balmes Sanitas, Barcelona, Spain.

Wan-Fai Ng (WF)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, and NIHR Biomedical Research Centre & NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Antónia Szántó (A)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.

Astrid Rasmussen (A)

Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Roberta Priori (R)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.

Chiara Baldini (C)

Rheumatology Unit, University of Pisa, Italy.

Berkan Armagan (B)

Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Burcugül Özkiziltaş (B)

Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.

Sonja Praprotnik (S)

Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia.

Yasunori Suzuki (Y)

Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Luca Quartuccio (L)

Division of Rheumatology, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, Udine, Italy.

Gabriela Hernández-Molina (G)

Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.

Nevsun Inanc (N)

Marmara University, School of Medicine, Istanbul, Turkey.

Elena Bartoloni (E)

Rheumatology Unit, Department of Medicine, University of Perugia, Italy.

Maureen Rischmueller (M)

Department of Rheumatology, The Queen Elizabeth Hospital, Discipline of Medicine, University of Adelaide, South Australia, Australia.

Fabiola Reis-de Oliveira (F)

Ribeirao Preto Medical School, University of São Paulo, Brazil.

Virginia Fernandes Moça Trevisani (V)

Division of Health Based Evidence, Federal University of São Paulo, Brazil.

Ciprian Jurcut (C)

Department of Internal Medicine, Carol Davila Central Military Emergency Hospital, Bucharest, Romania.

Gunnel Nordmark (G)

Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Francesco Carubbi (F)

Internal Medicine and Nephrology Unit, Department of Medicine, ASL Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.

Benedikt Hofauer (B)

Otorhinolaryngology, Head and Neck Surgery, Technical University Munich, Germany.

Valeria Valim (V)

University Hospital Cassiano Antonio Moraes (Hucam-Ufes/Ebserh), Federal University of Espírito Santo, Brazil.

Sandra G Pasoto (SG)

Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Brazil.

Soledad Retamozo (S)

Department of Rheumatology, Hospital Quirón Salud, Barcelona, Spain.

Fabiola Atzeni (F)

Rheumatology Unit, University of Messina, Italy.

Eva Fonseca-Aizpuru (E)

Department of Internal Medicine, Hospital de Cabueñes, Gijón, Spain.

Miguel López-Dupla (M)

Department of Internal Medicine, Hospital Joan XXIII, Tarragona, Spain.

Roberto Giacomelli (R)

Fondazione Policlinico Universitario Campus Bio-Medico, Roma, and Research Unit of Immuno-Rheumatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Italy.

Hideki Nakamura (H)

Division of Haematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan.

Miriam Akasbi (M)

Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Spain.

Kyle Thompson (K)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, and NIHR Biomedical Research Centre & NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Ildiko Fanny Horváth (I)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.

A Darise Farris (AD)

Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Edoardo Simoncelli (E)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.

Stefano Bombardieri (S)

Rheumatology Unit, University of Pisa, Italy.

Levent Kilic (L)

Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Abdurrahman Tufan (A)

Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.

Katja Perdan Pirkmajer (K)

Department of Rheumatology, University Medical Centre, Ljubljana, and Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Slovenia.

Yuhei Fujisawa (Y)

Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Salvatore De Vita (S)

Division of Rheumatology, University of Udine, Department of Medicine, University Hospital Santa Maria della Misericordia, Udine, Italy.

Kerem Abacar (K)

Marmara University, School of Medicine, Istanbul, Turkey.

Manuel Ramos-Casals (M)

Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, and Department of Medicine, University of Barcelona, Spain. mramos@clinic.cat.

Classifications MeSH